Literature DB >> 18172198

Disruption of the RIIbeta subunit of PKA reverses the obesity syndrome of Agouti lethal yellow mice.

Traci A Czyzyk1, Maria A Sikorski, Linghai Yang, G Stanley McKnight.   

Abstract

Agouti lethal yellow (A(y)) mice express agouti ectopically because of a genetic rearrangement at the agouti locus. The agouti peptide is a potent antagonist of the melanocortin 4 receptor (MC4R) expressed in neurons, and this leads to hyperphagia, hypoactivity, and increased fat mass. The MC4R signals through Gs and is thought to stimulate the production of cAMP and activation of downstream cAMP effector molecules such as PKA. Disruption of the RIIbeta regulatory subunit gene of PKA results in release of the active catalytic subunit and an increase in basal PKA activity in cells where RIIbeta is highly expressed. Because RIIbeta is expressed in neurons including those in the hypothalamic nuclei where MC4R is prominent we tested the possibility that the RIIbeta knockout might rescue the body weight phenotypes of the A(y) mice. Disruption of the RIIbeta PKA regulatory subunit gene in mice leads to a 50% reduction in white adipose tissue and resistance to diet-induced obesity and hyperglycemia. The RIIbeta mutation rescued the elevated body weight, hyperphagia, and obesity of A(y) mice. Partial rescue of the A(y) phenotypes was even observed on an RIIbeta heterozygote background. These results suggest that the RIIbeta gene mutation alters adiposity and locomotor activity by modifying PKA signaling pathways downstream of the agouti antagonism of MC4R in the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18172198      PMCID: PMC2224200          DOI: 10.1073/pnas.0710607105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Mutation of the RIIbeta subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue.

Authors:  J V Planas; D E Cummings; R L Idzerda; G S McKnight
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

Review 2.  Anatomy and regulation of the central melanocortin system.

Authors:  Roger D Cone
Journal:  Nat Neurosci       Date:  2005-05       Impact factor: 24.884

3.  Activation of the melanocortin-4 receptor mobilizes intracellular free calcium in immortalized hypothalamic neurons.

Authors:  Erika A Newman; Bioa-Xin Chai; Weizhen Zhang; Ji-Yao Li; John B Ammori; Michael W Mulholland
Journal:  J Surg Res       Date:  2006-03-31       Impact factor: 2.192

4.  Deletion of the RIIbeta-subunit of protein kinase A decreases body weight and increases energy expenditure in the obese, leptin-deficient ob/ob mouse.

Authors:  Kathryn J Newhall; David E Cummings; Michael A Nolan; G Stanley McKnight
Journal:  Mol Endocrinol       Date:  2004-12-23

5.  Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus.

Authors:  Gregory M Sutton; Bronwyn Duos; Laurel M Patterson; Hans-Rudolf Berthoud
Journal:  Endocrinology       Date:  2005-06-16       Impact factor: 4.736

Review 6.  Obesity-associated mutations in the human melanocortin-4 receptor gene.

Authors:  Robert G MacKenzie
Journal:  Peptides       Date:  2005-11-04       Impact factor: 3.750

7.  A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation.

Authors:  E J Michaud; S J Bultman; M L Klebig; M J van Vugt; L J Stubbs; L B Russell; R P Woychik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

8.  Agouti-related protein-deficient mice display an age-related lean phenotype.

Authors:  Katherine E Wortley; Keith D Anderson; Jason Yasenchak; Andrew Murphy; David Valenzuela; Sabrina Diano; George D Yancopoulos; Stanley J Wiegand; Mark W Sleeman
Journal:  Cell Metab       Date:  2005-12       Impact factor: 27.287

9.  Divergence of melanocortin pathways in the control of food intake and energy expenditure.

Authors:  Nina Balthasar; Louise T Dalgaard; Charlotte E Lee; Jia Yu; Hisayuki Funahashi; Todd Williams; Manuel Ferreira; Vinsee Tang; Robert A McGovern; Christopher D Kenny; Lauryn M Christiansen; Elizabeth Edelstein; Brian Choi; Olivier Boss; Carl Aschkenasi; Chen-yu Zhang; Kathleen Mountjoy; Toshiro Kishi; Joel K Elmquist; Bradford B Lowell
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

10.  Abnormalities of the somatotrophic axis in the obese agouti mouse.

Authors:  N M Martin; P A Houston; M Patterson; A Sajedi; D F Carmignac; M A Ghatei; S R Bloom; C J Small
Journal:  Int J Obes (Lond)       Date:  2006-03       Impact factor: 5.095

View more
  23 in total

1.  Phosphodiesterase inhibitor-dependent inverse agonism of agouti-related protein on melanocortin 4 receptor in sea bass (Dicentrarchus labrax).

Authors:  Elisa Sánchez; Vera Cruz Rubio; Darren Thompson; Juriaan Metz; Gert Flik; Glenn L Millhauser; José Miguel Cerdá-Reverter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

Review 2.  Local cAMP signaling in disease at a glance.

Authors:  Matthew G Gold; Tamir Gonen; John D Scott
Journal:  J Cell Sci       Date:  2013-10-15       Impact factor: 5.285

3.  Melanocortin-induced PKA activation inhibits AMPK activity via ERK-1/2 and LKB-1 in hypothalamic GT1-7 cells.

Authors:  Ellen Damm; Thomas R H Buech; Thomas Gudermann; Andreas Breit
Journal:  Mol Endocrinol       Date:  2012-02-23

4.  Lack of cAMP-response element-binding protein 1 in the hypothalamus causes obesity.

Authors:  Franck Chiappini; Lucas L Cunha; Jamie C Harris; Anthony N Hollenberg
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

5.  Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r.

Authors:  Elodie Le Pape; Thierry Passeron; Alessio Giubellino; Julio C Valencia; Rainer Wolber; Vincent J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

6.  Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Authors:  D E Adkins; K Aberg; J L McClay; J Bukszár; Z Zhao; P Jia; T S Stroup; D Perkins; J P McEvoy; J A Lieberman; P F Sullivan; E J C G van den Oord
Journal:  Mol Psychiatry       Date:  2010-03-02       Impact factor: 15.992

7.  Protein kinase A is a target for aging and the aging heart.

Authors:  Linda C Enns; Christina Pettan-Brewer; Warren Ladiges
Journal:  Aging (Albany NY)       Date:  2010-04       Impact factor: 5.682

Review 8.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

9.  Protein kinase A regulatory subunits in human adipose tissue: decreased R2B expression and activity in adipocytes from obese subjects.

Authors:  Giovanna Mantovani; Sara Bondioni; Luisella Alberti; Luisa Gilardini; Cecilia Invitti; Sabrina Corbetta; Marco A Zappa; Stefano Ferrero; Andrea G Lania; Silvano Bosari; Paolo Beck-Peccoz; Anna Spada
Journal:  Diabetes       Date:  2008-12-18       Impact factor: 9.461

10.  Attenuation of age-related metabolic dysfunction in mice with a targeted disruption of the Cbeta subunit of protein kinase A.

Authors:  Linda C Enns; John F Morton; Ruby Sue Mangalindan; G Stanley McKnight; Michael W Schwartz; Matt R Kaeberlein; Brian K Kennedy; Peter S Rabinovitch; Warren C Ladiges
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-09-23       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.